Enrollment complete in the 12 mg dose cohort (n=16) of the Phase 1b PIONEER trial of pociredir in sickle cell disease (SCD); initiated the 20 mg dose cohort ― ― On track to provide clinical data from ...

Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a leader in cellular metabolism and pyruvate kinase (PK) activation pioneering therapies for rare diseases, today reported business highlights and financial ...

Orchid Fertility Dubai is at the forefront of reproductive technology with an innovative answer to one of the biggest ...

Mount Vernon Nazarene University is pleased to announce the integration of Virtual Reality (VR) simulation into its nursing ...

This week's Guest Voice is Richard Bayliss, who talks about three coping tools he's found useful in living with sickle cell ...